Vol. 17/No. 6 | OncologyLive

Excessive Imaging in Early-Stage Breast Cancer Detailed in Study

March 17, 2016

A study involving nearly 30,000 patients diagnosed with early-stage breast cancer has found that up to 60% of these women received imaging tests such as CT, bone, and PET scans that were not medically justified, contrary to national guidelines.

A Good Problem to Have

March 15, 2016

Today, there are multiple choices of regimens in two different modalities that can either prolong survival or allow patients to live without disease progression or recurrence for several years.

Studies Mark Progress Against Triple-Negative Breast Cancer

March 15, 2016

The antibody–drug conjugate sacituzumab govitecan (IMMU-132) received a breakthrough therapy designation based on phase II trial data showing a response rate of 31% in heavily pretreated patients with metastatic TNBC. However, treatment advances are lagging behind those seen in other breast cancer phenotypes.

Diffusion-Weighted MRI Studies Explored at VCU Massey Cancer Center

March 14, 2016

The Department of Radiation Oncology at Virginia Commonwealth University Massey Cancer Center has long been at the forefront worldwide in the development of various radiation therapy technologies that are now considered standard and have become widely available.

Pancreatic Cancer Vaccine Makes Progress in Two Late-Stage Trials

March 10, 2016

The novel therapeutic vaccine algenpantucel-L, which is genetically engineered from human cell lines, is being evaluated in two phase III trials in patients with resected pancreatic cancer (IMPRESS) and borderline resectable or locally advanced unresectable pancreatic cancer (PILLAR).